(CercleFinance.com) – Mauna Kea Technologies announces today the appointment of Côme de La Tour du Pin as Chief Financial Officer and member of the Executive Committee.
“The appointment of Côme, combined with the recent arrival of Nathalie Lecoq as Deputy Chief Executive Officer, demonstrates the Company’s appeal for experienced, very high-level profiles,” said Sacha Loiseau, Chairman and Chief Executive Officer. from Mauna Kea Technologies.
Before joining Mauna Kea Technologies, Côme de La Tour du Pin was Chief Financial Officer of Lysogene, a gene therapy company in clinical development listed on Euronext, where he was in charge of financial planning and management, investor relations and fundraising.
Copyright © 2023 CercleFinance.com. All rights reserved.
Did you like this article ? Share it with your friends with the buttons below.
